Pfizer Covid-19 vaccine ‘works against rapid spread mutant strains’

The pharmaceutical giant and researchers from the University of Texas carried out lab tests on the strains, one of which was found in the UK while the other originated in South Africa.

The variants contain mutations including N501Y, an alteration in spike protein of the virus, which is a target for vaccines.

In the new study, which has not yet been peer-reviewed, blood samples were taken from 20 people who received the Pfizer vaccine.

Laboratory studies found that the samples had neutralising levels of antibodies which worked against the new strains.

The third lockdown in England was in response to the rapid spread of the mutant strain found in the south east, which has now spread to other parts of the UK.

SEE ALSO: City set for mass vaccination centre

A message from the Editor, Mark Waldron

You can subscribe here for unlimited access to Portsmouth news online - as well as fewer adverts, access to our digital edition and mobile app.

Our trial offer starts at just £2 a month for the first two months.